Mohs Micrographic Surgery and Reconstruction in the Optum Insurance Claims Database

Characterizing Trends in Mohs Micrographic Surgery and Complex Reconstruction in the Optum Healthcare Population

Status

Withdrawn

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04117373

Enrollment

Registered

2019-10-07

Start date

2019-07-01

Completion date

2019-12-31

Last updated

2020-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Interpolated Flap Repair, Mohs Micrographic Surgery, Skin Cancer

Brief summary

Mohs micrographic surgery (MMS) followed by skin reconstruction has been widely accepted for treatment of many skin cancers. To further characterize the trends in MMS and reconstruction for skin cancer, a retrospective analysis will be performed using the Optum© Clinformatics® DataMart de-identified commercial claims database from 2001-2016. The findings may provide critical data for future prospective studies in skin cancer treatments.

Interventions

None listed

Study design

Observational model

ECOLOGIC_OR_COMMUNITY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

1 Years to 99 Years

Inclusion criteria

\- All patients in the Optum© Clinformatics® database who have an ICD9 or ICD10 code for skin cancer and a corresponding CPT code specific for interpolated flap reconstruction

Exclusion criteria

Design outcomes

Primary

Measure	Time frame	Description
Primary cost	Claims from 2001-2016 will be analyzed	How does interpolation flap procedure cost differ across settings

Secondary

Measure	Time frame	Description
Predictors of inpatient vs. outpatient procedure	Claims from 2001-2016 will be analzyed	How does medical specialty or geographical location predict where the procedure is performed

Countries

United States

Outcome results